Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors
Cutis · 2023
DOI: 10.12788/cutis.0859 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cutis, 2023. Verfasst von Jordan L Bormann und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Bormann is from the University of Utah Health Dermatology, Salt Lake City. Dr. Kerkvliet is from the Department of Pathology, Sanford School of M…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Cholangiocarcinoma, Dermatitis, Melanoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dr. Bormann is from the University of Utah Health Dermatology, Salt Lake City. Dr. Kerkvliet is from the Department of Pathology, Sanford School of Medicine, University of South Dakota, Sioux Falls.
Zitieren
APA
Bormann, J. L., & Kerkvliet, A. M. (2023). Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors. Cutis. https://doi.org/10.12788/cutis.0859
Vancouver
Bormann JL, Kerkvliet AM. Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors. Cutis. 2023. doi:10.12788/cutis.0859
BibTeX
@article{Bormann2023,
author = {Bormann, Jordan L and Kerkvliet, Amy M},
title = {Granulomatous Dermatitis in a Patient With Cholangiocarcinoma Treated With BRAF and MEK Inhibitors},
journal = {Cutis},
year = {2023},
doi = {10.12788/cutis.0859}
}
EUVIMED